Friday, July 25, 2008

Prostate-cancer and the Hope

prostate cancer; prostate cancer research



Erudites think they almost have an efficient answear for the most deadly cancer-type from which men are suffering nowdays. As We (unfortunately) know, the aggressive prostate-cancer is lethal and the most harmful type of some of cancer-types. More than 10 thousand people per annum have to face with the deadly cancer only in the United Kingdom. It is so stern, and aggressive, so far the chemotherapy was a little hope-ray, but as it comes to light the chemotherapy merely can provides a little bit longer life.


prostate cancer alternative treatment


In turn, research workers might take control of its hormon-making mechanism. According to facts, tumors can expanse and broaden theirs territory because of testosterone. But, so far, they don’t recognize that tumor can produce testosterone too, that is to say, they can be treated as a self-sufficient killers, tumor can trigger its expansion.

Now, prospectors developed a new medicine – Albiraterone - which is in testing-phase, but its achivements are promising. It could be the cure against the aggressive prostate-cancer. Cliniq-investigations have showed that it works in 80 percentage of all cases.

How does it work? Albiraterone as an antimatter is able to block the producing mechanism of testosteron of tumors. As far as erudites concerned, its effectiveness is enough to hope it will be the solvation. So far, they managed tests on 1200 voluntary-patient, among the candidates there were a lots of people who have been reporting about positive progress.

According to the test of Journal of Clinical Oncology,shrinkings of tumors were obviously, and the volume of emissed protein were unambiguously moderated.

There is a HOPE. But, naturally, we have to wait, until the full of tests, and side effects will be known, and then… hope becomes fact.

Tuesday, May 20, 2008

Coping with Alzheimer

Erudites developed a new medicine, which may reverse the Alz-Heimer process.

These scientiest made a very genuine mechanism, through its efficiency they able to reverse the malignant Alz-Heimer's symptomes. This medicine can make a connection with the brain-cells, due to the animal-tests, it prooved appropriate opportunity. Scientist are in great hope that they can testing on human side too as soon as possible.



Medicine is blocking enzimes, which are blamable to cause brain-placks (placks contain calcium, lard eq) have enormous and key-role in the evolvation of Alz-Heimer. If everything goes well, this medicine will be available in trading circulation in 10 years. The question is, whether the medicine is able to get through the human blood-brain-hurdle. When the medicine was directly injected in brains of rats, the consequence was a telling decreasing of the volume of brainplacks (the number of placks were eliminated with 50 percentage in 4 hours).

Thursday, February 7, 2008

DermaVir Bandage Against AIDS

There are so many serious virus, bacteria all over the World evolved, emitted, designed by many different ways (im writing in this way, 'cause people can estabilish deadly by voracious inhuman behaviorism).

AIDS, this 4 words mean a lot for those who got contact with this virulent contagion, or keeping their eyes open and watching the news. According to the European Commission, more and more people get infection year by year, especielly from the range of 15 - 25 age, and the survey added: this is among heterosexual people. So far as im concerned, this means that in the age class of juvenile, teenage this is very partycular problem. They do not care enough of themselves, they do not be enough prudence.





Thousands of people in pharmaceutical sector have been trying to develope a new medicine, a new prodecure in the last decade to ward off this deadly infection.

In Hungary, an atomic ray of hopeness has sparked in the course of estabilishing a new bandage - called aids bandage - against this volarious epidemic. The new solid opportunity against AIDS experimented by Professor Julianna Lisziewicz in United States will be introduced and available in 4-5 years. There are not any other similar medicine in the World with the effectiveness of this so-called therapy vaccine bandage, Professor Julianna said.

This is not mainly a preventive mechanism, this has to be used during the illness, as a treatment. In Practise the bandage is stinked to the back of people, where the vaccine yielded by DNA of HIV virus reaches Langerhans-cells. Cells are discovering the active substance of DermaVir (this is the name of medicine) and they get its encoded information travelled to lymph node, this process is inducing killer-cells which devour infected cells.

This method is safe for people, it was proofed by many tests.

Tuesday, November 27, 2007

Health Includes Body and Soul - Possibilities in Hungary

Firstly, i must confess honestly recently i hadnt had enough
time to post new and attracting stuffs. But, now, i decided that
it would be benign if we take a trip in the sphera of the therapy
process, methods to discover how can people ease their
pain with the newest and classics therapy-methods.

Im just about to bolster another blogger's theme. Because our
first visit has taken place in Hungary, especielly in its most notable
therapy and spa centrum, Hajdúszoboszló. Do not hesitate and click on the mentioned name to widen mind in the light of this theme.

As we know the therapeutics has got some scope in wide range. From the healthy hot springs through the pleasure park, where are some provided speciel processes which facilitate the tranquil healing up. Hungary has a lot of opportunities out of these, one of the biggest favoured place is Hajduszoboszlo. Make a little ad for it, it is a must, but, it is without any capitalization goals, its a pure object, to make greater renown for this health paradise, for the sake of people.

Wednesday, August 29, 2007

Are we close ties with God?

"God has not given us any disease for which he has not provided a remedy." Paracelsus

I have been crawling and surfing on the Internet, and at last bumped into a very gripping
doctor of TCM thesis by Ricardo Serrano, entitled: Cure and Cause of Cancer is Within You.

"The cure and cause of cancer is within you. The cause of cancer is a weakening of your immune system (Wei Qi) which is termed Chronic Immune (Wei) Dysfunction Syndrome (CIDS). I will elaborate more on this theory at the Cause web page and you will know why Traditional Chinese Medicine works.

The cure for cancer is strengthening your immune system (Wei Qi) which can be done naturally with powerful tools such as herbal formulas (detoxification and nourishment), meditation, acupuncture/moxibustion, pranic healing, and nutritional supplementation in an integrated manner. I will elaborate more on this at the Cure web page.

My theories and system of cure is rational, time tested and scientifically proven for centuries according to Traditional Chinese medical theory on strengthening Wei Qi as practiced in mainland China and everywhere in the world.

I believe that Our Creator provides us with powerful tools from nature and within us to deal with our health challenges as long as we have faith in the healing power within ourselves and use Mother Earth's herbs and special foods."

He looks convincing, its time to be hopeful mankind's ability is enough to reveal all causes of cancers by and by. As im concerned: im flurried.

Sunday, June 24, 2007

Cancer Research a'la hungarian method


Huge hungarian achievement in cancer research

Professor Istvan Majoros' invention named dendrimer can devour directly the sick cells.

It will be the biggest performance in the story of the hungarian cancer research if the artificial dendrim molecule adaptable on people too.


 
According to the erudite the cell can be treated as trojan woodhorse able to dispatch some medicine to the cancered cells, which annex it - in the hope of the important vitamines - whereby the traditional kemotherapy might be readily superfluos.

The new method can only deploy for the treatment of the evolved cancer, in turn its dosing can be revised by prefrences, and it has not got any spillover.

The professor who lives in USA since 1990 is trusting in connection with the application of the new developed method, he said, in the course of animal tests they destroyed the breast-cancer successfully. At this moment the animal attempts are going, and the deploying of the new dendrin is likely to be a grave counterpart, and cope with whatever cancer types.

The discovery was welcomed keenly by the profession, for example Michigan subsidies the professor's research with notable sum of money. Istan Majoros said, all terms are available in the United States to the research, however, there are very stringent yearly probes, in which the researcher groups are examined, and make the subsidies in line with the achievements.

Istvan Majoros added the sick people are the most important for himself than the money, he tries to do his best in order to rise the quality level of the Hungarian cancer research.

Saturday, May 5, 2007

The Cost of Developing a New Drug


This particular column stems from the CBO's Study, named: Research and Development in the Pharmaceutical Industry - i would like to express my satisfaction and happiness in connection with this study, read it because it is advisable:

Research and development costs vary widely from one new drug to the next. Those costs depend on the type of drug being developed, the likelihood of failure, and whether the drug is based on a molecule not used before in any pharmaceutical product (a new molecular entity, or NME) or instead is an incremental modification of an existing drug.

Innovative Drugs
A recent, widely circulated estimate put the average cost of developing an innovative new drug at more than $800 million, including expenditures on failed projects and the
value of forgone alternative investments.1 Although that average cost suggests that new-drug discovery and development can be very expensive, it reflects the research strategies and drug-development choices that companies make on the basis of their expectations about future revenue. If companies expected to earn less from future drug sales, they would alter their research strategies to lower their average R&D spending per drug. Moreover, that
estimate represents only NMEs developed by a sample of large pharmaceutical firms. Other types of drugs often cost much less to develop (although NMEs have been the source of most of the major therapeutic advances in pharmaceuticals).

The study that produced that cost estimate also calculated how long it takes to develop a new drug and the relative contribution of capital costs to a drug’s total R&D costs. On average, developing an innovative new drug takes about 12 years, the study concluded, and a firm’s actual expenditures make up only about half of the total reported cost. The rest represents the financial cost of tying up investment capital in multiyear drugdevelopment
projects, earning no return until and unless a project succeeds. That “opportunity cost” of capital reflects forgone interest or earnings from alternative uses of the capital. (Opportunity costs are common to all innovative industries, but they are particularly large for pharmaceutical firms because of the relatively long time that is often required to develop a new drug.)

Research and development spending per NME has grown significantly in recent years, for various reasons. First, failure rates in clinical trials have increased, possibly because
of greater research challenges or a willingness to test riskier drugs in such trials. Second, larger drug firms are said to have shifted the focus of their development efforts away from drugs for acute illnesses and toward drugs for chronic illnesses. Drugs that treat chronic illnesses can be more expensive to develop because they often require larger and longer clinical trials. Third, greater technological complexity in drug development and greater specificity in disease targets have helped to raise average R&D costs, as firms now identify drugs with particular molecular characteristics rather than using trial-and-error methods
to find compounds that work in some desired way. Not all new molecular entities provide unique therapeutic functions. Many NMEs are so-called “me-too” drugs. Despite that name, they are not necessarily imitations of other drugs. Rather, they may be innovative products that lost the race to be the first drug on the market in a given therapeutic class (such as antidepressants, antibiotics, or antihistamines). Such products can benefit consumers by
competing with, and sometimes improving on, the pioneering drug in a class.